Erythropoietin Decreases the Occurrence of Myocardial Fibrosis by Inhibiting the NADPH-ERK-NF-κB Pathway
Publisher: Karger
E-ISSN: 1421-9751|133|2|97-108
ISSN: 0008-6312
Source: Cardiology, Vol.133, Iss.2, 2016-0, pp. : 97-108
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract